Published in J Pathol on June 28, 2017
Integrated genomic characterization of endometrial carcinoma. Nature (2013) 14.29
Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer (2009) 14.17
F4/80, a monoclonal antibody directed specifically against the mouse macrophage. Eur J Immunol (1981) 12.96
Targeting PI3K signalling in cancer: opportunities, challenges and limitations. Nat Rev Cancer (2009) 12.92
TGFβ signalling in context. Nat Rev Mol Cell Biol (2012) 8.08
Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems. Proc Natl Acad Sci U S A (1999) 7.88
Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet (2009) 6.98
Abrogation of TGF beta signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis. Cancer Cell (2008) 6.78
Cancer Statistics, 2017. CA Cancer J Clin (2017) 4.77
Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies. Cancer Res (1997) 4.32
Cre/loxP-mediated inactivation of the murine Pten tumor suppressor gene. Genesis (2002) 4.23
Role of transforming growth factor-beta signaling in cancer. J Natl Cancer Inst (2000) 3.63
IL-17 produced by neutrophils regulates IFN-gamma-mediated neutrophil migration in mouse kidney ischemia-reperfusion injury. J Clin Invest (2009) 3.30
Abnormal angiogenesis but intact hematopoietic potential in TGF-beta type I receptor-deficient mice. EMBO J (2001) 3.24
Chemokines and chemokine receptors: new insights into cancer-related inflammation. Trends Mol Med (2010) 3.10
Axis of evil: molecular mechanisms of cancer metastasis. Oncogene (2003) 2.81
Role of transforming growth factor-beta superfamily signaling pathways in human disease. Biochim Biophys Acta (2008) 2.72
Cre-mediated recombination in cell lineages that express the progesterone receptor. Genesis (2005) 2.67
SMAD4-deficient intestinal tumors recruit CCR1+ myeloid cells that promote invasion. Nat Genet (2007) 2.39
ALK5- and TGFBR2-independent role of ALK1 in the pathogenesis of hereditary hemorrhagic telangiectasia type 2. Blood (2007) 2.17
Conditional loss of uterine Pten unfailingly and rapidly induces endometrial cancer in mice. Cancer Res (2008) 2.15
Type I and II endometrial cancers: have they different risk factors? J Clin Oncol (2013) 2.01
Tumor associated macrophages and neutrophils in cancer. Immunobiology (2013) 1.87
BMPR2 is required for postimplantation uterine function and pregnancy maintenance. J Clin Invest (2013) 1.70
Abrogation of TGF-beta signaling enhances chemokine production and correlates with prognosis in human breast cancer. J Clin Invest (2009) 1.68
Chemokines in tumor progression and metastasis. Oncotarget (2013) 1.64
CXCR4 expression increases liver and lung metastasis in a mouse model of pancreatic cancer. Gastroenterology (2005) 1.61
Macrophage plasticity and polarization in liver homeostasis and pathology. Hepatology (2014) 1.48
Identification of molecular markers and signaling pathway in endometrial cancer in Hong Kong Chinese women by genome-wide gene expression profiling. Oncogene (2006) 1.42
Loss of TGF-β signaling and PTEN promotes head and neck squamous cell carcinoma through cellular senescence evasion and cancer-related inflammation. Oncogene (2011) 1.38
Recurrent endometrial cancer: patterns of recurrent disease and assessment of prognosis. Clin Radiol (2007) 1.33
Overexpression of CXCL5 mediates neutrophil infiltration and indicates poor prognosis for hepatocellular carcinoma. Hepatology (2012) 1.31
MUC1 and metastatic cancer: expression, function and therapeutic targeting. Cell Adh Migr (2013) 1.31
TGF-β receptor II loss promotes mammary carcinoma progression by Th17 dependent mechanisms. Cancer Discov (2011) 1.26
Transforming growth factor β receptor type 1 is essential for female reproductive tract integrity and function. PLoS Genet (2011) 1.20
Loss of transforming growth factor-beta signaling in mammary fibroblasts enhances CCL2 secretion to promote mammary tumor progression through macrophage-dependent and -independent mechanisms. Neoplasia (2010) 1.06
The synergistic effect of Mig-6 and Pten ablation on endometrial cancer development and progression. Oncogene (2010) 1.03
Prognostic significance of gross myometrial invasion with endometrial cancer. Obstet Gynecol (1996) 1.02
Clinical significance of CD163⁺ tumor-associated macrophages in patients with adult T-cell leukemia/lymphoma. Cancer Sci (2013) 0.98
Transforming growth factor-beta, estrogen, and progesterone converge on the regulation of p27Kip1 in the normal and malignant endometrium. Cancer Res (2007) 0.94
Transforming growth factor beta signaling is disabled early in human endometrial carcinogenesis concomitant with loss of growth inhibition. Cancer Res (2002) 0.93
A novel inflammatory pathway involved in leukocyte recruitment: role for the kinin B1 receptor and the chemokine CXCL5. J Immunol (2007) 0.93
PTEN controls β-cell regeneration in aged mice by regulating cell cycle inhibitor p16ink4a. Aging Cell (2013) 0.92
Synergistic action of Smad4 and Pten in suppressing pancreatic ductal adenocarcinoma formation in mice. Oncogene (2009) 0.89
Loss of SMAD4 from colorectal cancer cells promotes CCL15 expression to recruit CCR1+ myeloid cells and facilitate liver metastasis. Gastroenterology (2013) 0.89
Typical and atypical metastatic sites of recurrent endometrial carcinoma. Cancer Imaging (2013) 0.88
Loss of growth regulation by transforming growth factor-beta (TGF-beta) in human cancers: studies on endometrial carcinoma. Semin Reprod Endocrinol (1999) 0.85
CXCL5/CXCR2 axis promotes bladder cancer cell migration and invasion by activating PI3K/AKT-induced upregulation of MMP2/MMP9. Int J Oncol (2015) 0.85
TGFbeta signaling supports survival and metastasis of endometrial cancer cells. Cancer Manag Res (2009) 0.84
TGFBR1 is required for mouse myometrial development. Mol Endocrinol (2014) 0.84
CCL9 Induced by TGFβ Signaling in Myeloid Cells Enhances Tumor Cell Survival in the Premetastatic Organ. Cancer Res (2015) 0.84
LKB1 loss promotes endometrial cancer progression via CCL2-dependent macrophage recruitment. J Clin Invest (2015) 0.82
Mig-6 suppresses endometrial cancer associated with Pten deficiency and ERK activation. Cancer Res (2014) 0.79
Constitutively active transforming growth factor β receptor 1 in the mouse ovary promotes tumorigenesis. Oncotarget (2016) 0.78
Effects of transforming growth factors and regulation of their mRNA levels in two human endometrial adenocarcinoma cell lines. J Steroid Biochem Mol Biol (1992) 0.78
Loss of CDH1 and Pten accelerates cellular invasiveness and angiogenesis in the mouse uterus. Biol Reprod (2013) 0.78
Expression of TGF-beta type I and II receptors in normal and cancerous human endometrium. Cancer Lett (2002) 0.77
Endometrial Carcinoma: Specific Targeted Pathways. Adv Exp Med Biol (2017) 0.76
Loss of Cdh1 and Trp53 in the uterus induces chronic inflammation with modification of tumor microenvironment. Oncogene (2014) 0.76
Distinct functions and regulation of epithelial progesterone receptor in the mouse cervix, vagina, and uterus. Oncotarget (2016) 0.76
The essential role of GATA transcription factors in adult murine prostate. Oncotarget (2016) 0.75
Endogenous YAP1 activation drives immediate onset of cervical carcinoma in situ in mice. Cancer Sci (2020) 0.75
TGFβ superfamily signaling and uterine decidualization. Reprod Biol Endocrinol (2017) 0.75
Disruption of postnatal folliculogenesis and development of ovarian tumor in a mouse model with aberrant transforming growth factor beta signaling. Reprod Biol Endocrinol (2017) 0.75
Pten and Dicer1 loss in the mouse uterus causes poorly differentiated endometrial adenocarcinoma. Oncogene (2020) 0.75